10/30/24 19:21 | 10/29/24 | SYBX | Health | Drug | Pharmaceutical Preparations | Dooley Mary Beth | MA | O | Head of | S | 0 | 1.40 | 0 | 0 | -1 | 15 | D | | | | | | | | | | | | | | |
4/4/24 16:00 | 4/2/24 | SYBX | Health | Drug | Pharmaceutical Preparations | Dooley Mary Beth | MA | O | Head of | S | 0 | 1.73 | 0 | 0 | -1 | 15 | D | | | | | | | | | | | | | | |
4/4/24 16:00 | 4/2/24 | SYBX | Health | Drug | Pharmaceutical Preparations | Awad Antoine | MA | O | COO | S | -1 | 1.73 | 0 | 0 | -1 | 34 | D | | | | | | | | | | | | | | |
4/5/23 16:15 | 4/3/23 | SYBX | Health | Drug | Pharmaceutical Preparations | Brennan Aoife | MA | DO | See Rema | S | -11 | 0.5758 | 0 | -19 | -7 | 256 | D | | | | | | | | | | | | | | |
4/5/23 16:15 | 4/3/23 | SYBX | Health | Drug | Pharmaceutical Preparations | Awad Antoine | MA | O | COO | S | -4 | 0.5758 | 0 | -6 | -8 | 75 | D | | | | | | | | | | | | | | |
4/5/23 16:15 | 4/3/23 | SYBX | Health | Drug | Pharmaceutical Preparations | Jensen Michael Vangsted | MA | O | CFO | S | -1 | 0.5758 | 0 | -3 | -5 | 47 | D | | | | | | | | | | | | | | |
4/6/22 16:39 | 4/4/22 | SYBX | Health | Drug | Pharmaceutical Preparations | Brennan Aoife | MA | DO | See Rema | S | -22 | 2.45 | 0 | -9 | -3 | 275 | D | | | | | | | | | | | | | | |
4/6/22 16:38 | 4/4/22 | SYBX | Health | Drug | Pharmaceutical Preparations | Awad Antoine | MA | O | COO | S | -6 | 2.45 | 0 | -3 | -3 | 81 | D | | | | | | | | | | | | | | |
2/14/19 16:06 | 2/12/19 | SYBX | Health | Drug | Pharmaceutical Preparations | Miller Paul Francis | MA | O | Chief Sc | S.m | -88 | 9.75 | 0 | -9 | -16 | 48 | D | | | | | | | | | | | | | | |
10/19/18 16:06 | 10/18/18 | SYBX | Health | Drug | Pharmaceutical Preparations | Miller Paul Francis | MA | O | Chief Sc | S | -29 | 9.77 | 0 | -3 | -5 | 57 | D | | | | | | | | | | | | | | |
9/19/18 16:05 | 9/18/18 | SYBX | Health | Drug | Pharmaceutical Preparations | Miller Paul Francis | MA | O | Chief Sc | S | -39 | 13.05 | 0 | -3 | -5 | 60 | D | | | | | | | | | | | | | | |
9/7/18 16:05 | 9/5/18 | SYBX | Health | Drug | Pharmaceutical Preparations | Miller Paul Francis | MA | O | Chief Sc | S | -38 | 12.55 | 0 | -3 | -5 | 63 | D | | | | | | | | | | | | | | |
8/31/18 16:05 | 8/29/18 | SYBX | Health | Drug | Pharmaceutical Preparations | Miller Paul Francis | MA | O | Chief Sc | S.m | -29 | 9.76 | 0 | -3 | -4 | 66 | D | | | | | | | | | | | | | | |
7/19/18 16:05 | 7/18/18 | SYBX | Health | Drug | Pharmaceutical Preparations | Miller Paul Francis | MA | O | Chief Sc | S | -33 | 11.01 | 0 | -3 | -4 | 69 | D | | | | | | | | | | | | | | |
6/21/18 16:06 | 6/19/18 | SYBX | Health | Drug | Pharmaceutical Preparations | Miller Paul Francis | MA | O | Chief Sc | S.m | -29 | 9.77 | 0 | -3 | -4 | 72 | D | | | | | | | | | | | | | | |
12/2/16 19:11 | 12/1/16 | MIRN | Health | Drug | Pharmaceutical Preparations | Irvin Jon | TX | O | VP,Finan | S | 0 | 1.43 | 0 | 0 | -4 | 8 | D | | -76 | -67 | -40 | -6 | 15 | -1 | 1 | 2 | 4 | 20 | 50 | | |
11/15/16 19:10 | 11/11/16 | MIRN | Health | Drug | Pharmaceutical Preparations | Irvin Jon | TX | O | VP,Finan | S | 0 | 1.45 | 0 | 0 | -2 | 8 | D | | -80 | -71 | -69 | -35 | -19 | 5 | -3 | -2 | 27 | 34 | 92 | | |
11/2/16 18:56 | 11/1/16 | MIRN | Health | Drug | Pharmaceutical Preparations | Irvin Jon | TX | O | VP,Finan | S | 0 | 1.28 | 0 | 0 | -3 | 8 | D | | -78 | -72 | -70 | -37 | -30 | -19 | -2 | -4 | 1 | 24 | 85 | 70 | |
10/12/16 16:26 | 10/11/16 | MRIN | Health | Drug | Pharmaceutical Preparations | Irvin Jon | TX | O | VP,Finan | S | 0 | 1.83 | 0 | 0 | -2 | 8 | D | -72 | -33 | -20 | 0 | -7 | -4 | -8 | -2 | 0 | 2 | -4 | 6 | -21 | |
10/5/16 18:21 | 10/3/16 | MIRN | Health | Drug | Pharmaceutical Preparations | Irvin Jon | TX | O | VP,Finan | S | 0 | 1.93 | 0 | 0 | -3 | 8 | D | | -74 | -55 | -57 | -40 | -26 | -8 | -4 | 0 | 0 | -34 | 0 | 12 | |